ananta medicare
ENDLESS CARE ABOUT YOUR HEALTH
News
A multiple sclerosis drug has been tested
11.11.2021

MSD has published Phase II study data suggesting the candidate is effective to treat exacerbations of relapsing multiple sclerosis

An ultra-effective antibiotic for tuberculosis
08.11.2021

The risks of multi-drug resistant tuberculosis have been significantly exacerbated due to the pandemic

Tramadol is more dangerous than codeine
04.11.2021

Compared to other opioids, tramadol is associated with a higher risk of adverse outcomes

Defeating Clostridiosis
02.11.2021

The biotech company and its candidate VE303 have demonstrated success in treating Clostridioides difficile infections

HEPA filters can clean the air from Sars-CoV-2
28.10.2021

High efficiency HEPA air filters can remove SARS-CoV-2 particles from the air

An effective antibody for multiple sclerosis
25.10.2021

Scientists from the Karolinska Institute have compared frequently prescribed medications for multiple sclerosis and have identified the most effective of them

Keytruda is effective for cervical cancer
21.10.2021

Keytruda has shown improved survival rate in chemotherapy with or without bevacizumab in patients with 3 types of cervical cancer

New orphan drug by AstraZeneca
18.10.2021

AstraZeneca has purchased a new orphan drug

Osteoporosis. Diagnostic and treatment tactics in modern practice of an internist
12.10.2021

On October 8, 2021 Ananta Medicare took an active part in holding an all-Ukrainian interdisciplinary scientific and practical conference with international participation of UMDA - a century of innovative directions and scientific achievements

Nasal immunomodulator for Covid-19
11.10.2021

Scientists believe that the inhaled form may help the drug to affect the lungs directly